Kite Pharma

This #WorldInclusionDay, we’re highlighting colleagues who champion inclusion, drive innovation and create a more connected environment. Our Employee Resource Groups (ERG) play a key role, and we’re proud to announce the launch of our new Disability Inclusion ERG, creating a community for employees living with disabilities. Together with Gilead Sciences, we’re fostering a culture where everyone belongs. #GileadLife #PassThePhoneChallenge

We look forward to connecting with the #celltherapy community and sharing our latest research at the APBMT 2024 Annual Meeting in Singapore this weekend. #APBMT2024

Cancer doesn’t pause, and neither do we. On #NationalManufacturingDay, we celebrate our manufacturing and supply chain teams who work around the clock to help rapidly and reliably deliver individualized cell therapies to patients. 

#KiteNews: Announcing the U.S. FDA has granted a Regenerative Medicine Advanced Therapy Designation for the evaluation of our CAR T-cell therapy as first-line treatment for high-risk large B-cell lymphoma. This status allows access to the FDA’s accelerated pathways, including fast track and breakthrough therapy designation programs. #celltherapy Read more: https://bit.ly/3Y9QbnB

Southern California-based team members had an incredible time volunteering during our Service Day at the Los Angeles LGBT Center, one of our valued community partners. Hosted by our Pride Alliance employee resource group, the day was filled with connection, teamwork and supporting a fantastic organization. At Kite, we’re proud to provide our colleagues with time to volunteer and give back to the communities where we live and work.

It’s crucial that treatments like CAR T-cell therapies are available to patients who need them – no matter where they live. We’re pleased to sponsor Tennessee Oncology’s new film in the Union for International Cancer Control (UICC) series Rewriting Cancer, produced by BBC StoryWorks Commercial Productions, which explores how we’re bringing innovative therapies, such as cell therapies, closer to patients.    #RewritingCancer

We were excited to kick off our #HispanicHeritageMonth celebrations with a networking event and silent auction hosted by our Gileados employee resource group. A special thank you to Gileados for bringing us together to honor the Hispanic community this month and all year long.

I was thrilled to join Priti Hegde, Flavius Martin and Anna Marie Tuazon, PhD, MBA to kick off the oncology session at Gilead’s annual Science Day last week. Our team was proud to share how Kite and Gilead are pushing the boundaries of science to advance cell therapy for patients.   This annual event isn't just a celebration, it's a powerful reminder of our progress and the exciting path ahead. The discussions around new research, exploration of future directions and shared commitment across our teams highlight the impact we can have.     At Kite Pharma and Gilead Sciences, our commitment is stronger than ever to deliver transformative therapies and profoundly impact patient lives, and I can't wait to see what we achieve together.    #GileadLife 

We were grateful for the opportunity to connect with the #celltherapy community at the All Together Against Cancer Movement (TJCC) Congress in Brazil. Once again, we proudly contributed to The Merula Award, honoring individuals who are dedicated to improving cancer care in Brazil. We thank the recipients for their commitment to patients. TJCC - Movimento Todos Juntos Contra o Câncer

A special thank you to Lorna Warwick, CEO of the Lymphoma Coalition, for joining the Kite team during Blood Cancer Awareness Month. Lorna highlighted the Lymphoma Coalition’s important work improving the lives of people with lymphoma around the world and emphasized the need for ongoing education and support. #BloodCancerAwarenessMonth